BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 26714815)

  • 1. Left Ventricular Tonic Contraction as a Novel Biomarker of Cardiomyopathy in Duchenne Muscular Dystrophy.
    Su JA; Ramos-Platt L; Menteer J
    Pediatr Cardiol; 2016 Apr; 37(4):678-85. PubMed ID: 26714815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy.
    Jefferies JL; Eidem BW; Belmont JW; Craigen WJ; Ware SM; Fernbach SD; Neish SR; Smith EO; Towbin JA
    Circulation; 2005 Nov; 112(18):2799-804. PubMed ID: 16246949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry.
    Connuck DM; Sleeper LA; Colan SD; Cox GF; Towbin JA; Lowe AM; Wilkinson JD; Orav EJ; Cuniberti L; Salbert BA; Lipshultz SE;
    Am Heart J; 2008 Jun; 155(6):998-1005. PubMed ID: 18513510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac Involvement in Duchenne Muscular Dystrophy and Related Dystrophinopathies.
    Mavrogeni SI; Markousis-Mavrogenis G; Papavasiliou A; Papadopoulos G; Kolovou G
    Methods Mol Biol; 2018; 1687():31-42. PubMed ID: 29067654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive left ventricular dysfunction and myocardial fibrosis in Duchenne and Becker muscular dystrophy: a longitudinal cardiovascular magnetic resonance study.
    Aikawa T; Takeda A; Oyama-Manabe N; Naya M; Yamazawa H; Koyanagawa K; Ito YM; Anzai T
    Pediatr Cardiol; 2019 Feb; 40(2):384-392. PubMed ID: 30564867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect and safety of treatment with ACE-inhibitor Enalapril and β-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy - a randomized, double-blind, placebo-controlled trial.
    Dittrich S; Graf E; Trollmann R; Neudorf U; Schara U; Heilmann A; von der Hagen M; Stiller B; Kirschner J; Pozza RD; Müller-Felber W; Weiss K; von Au K; Khalil M; Motz R; Korenke C; Lange M; Wilichowski E; Pattathu J; Ebinger F; Wiechmann N; Schröder R;
    Orphanet J Rare Dis; 2019 May; 14(1):105. PubMed ID: 31077250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised placebo-controlled trial of combination ACE inhibitor and beta-blocker therapy to prevent cardiomyopathy in children with Duchenne muscular dystrophy? (DMD Heart Protection Study): a protocol study.
    Bourke JP; Watson G; Muntoni F; Spinty S; Roper H; Guglieri M; Speed C; McColl E; Chikermane A; Jayawant S; Adwani S; Willis T; Wilkinson J; Bryant A; Chadwick T; Wood R; Bushby K;
    BMJ Open; 2018 Dec; 8(12):e022572. PubMed ID: 30573480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of angiotensin-converting enzyme inhibitors and/or beta blockers on the cardiomyopathy in Duchenne muscular dystrophy.
    Viollet L; Thrush PT; Flanigan KM; Mendell JR; Allen HD
    Am J Cardiol; 2012 Jul; 110(1):98-102. PubMed ID: 22463839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precordial R wave height does not correlate with echocardiographic findings in boys with Duchenne muscular dystrophy.
    Thrush PT; Edward N; Flanigan KM; Mendell JR; Allen HD
    Congenit Heart Dis; 2013; 8(6):561-7. PubMed ID: 23510265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantation of a left ventricular assist device as a destination therapy in Duchenne muscular dystrophy patients with end stage cardiac failure: management and lessons learned.
    Iodice F; Testa G; Averardi M; Brancaccio G; Amodeo A; Cogo P
    Neuromuscul Disord; 2015 Jan; 25(1):19-23. PubMed ID: 25444433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambulatory Monitoring and Arrhythmic Outcomes in Pediatric and Adolescent Patients With Duchenne Muscular Dystrophy.
    Villa CR; Czosek RJ; Ahmed H; Khoury PR; Anderson JB; Knilans TK; Jefferies JL; Wong B; Spar DS
    J Am Heart Assoc; 2015 Dec; 5(1):. PubMed ID: 26722125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of left ventricular remodeling in patients with Duchenne Muscular Dystrophy: a cardiac MRI study of ventricular geometry, global function, and strain.
    Mazur W; Hor KN; Germann JT; Fleck RJ; Al-Khalidi HR; Wansapura JP; Chung ES; Taylor MD; Jefferies JL; Benson DW; Gottliebson WM
    Int J Cardiovasc Imaging; 2012 Jan; 28(1):99-107. PubMed ID: 21222036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular function and response to enalapril in patients with duchenne muscular dystrophy during the second decade of life.
    Ramaciotti C; Heistein LC; Coursey M; Lemler MS; Eapen RS; Iannaccone ST; Scott WA
    Am J Cardiol; 2006 Sep; 98(6):825-7. PubMed ID: 16950195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac profile of asymptomatic children with Becker and Duchenne muscular dystrophy under treatment with steroids and with/without perindopril.
    Mavrogeni S; Giannakopoulou A; Papavasiliou A; Markousis-Mavrogenis G; Pons R; Karanasios E; Noutsias M; Kolovou G; Papadopoulos G
    BMC Cardiovasc Disord; 2017 Jul; 17(1):197. PubMed ID: 28738778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration in Left Ventricular Contractile Function Develops in Puppies With Duchenne Muscular Dystrophy.
    Ghaleh B; Barthélemy I; Sambin L; Bizé A; Hittinger L; Blot S; Su JB
    J Am Soc Echocardiogr; 2020 Jan; 33(1):120-129.e1. PubMed ID: 31611157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Speckle-Tracking Echocardiography in Children With Duchenne Muscular Dystrophy: A Prospective Multicenter Controlled Cross-Sectional Study.
    Amedro P; Vincenti M; De La Villeon G; Lavastre K; Barrea C; Guillaumont S; Bredy C; Gamon L; Meli AC; Cazorla O; Fauconnier J; Meyer P; Rivier F; Adda J; Mura T; Lacampagne A
    J Am Soc Echocardiogr; 2019 Mar; 32(3):412-422. PubMed ID: 30679141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying evidence of cardio-renal syndrome in patients with Duchenne muscular dystrophy using cystatin C.
    Villa CR; Kaddourah A; Mathew J; Ryan TD; Wong BL; Goldstein SL; Jefferies JL
    Neuromuscul Disord; 2016 Oct; 26(10):637-642. PubMed ID: 27542440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural History of Cardiomyopathy in Adult Dogs With Golden Retriever Muscular Dystrophy.
    Guo LJ; Soslow JH; Bettis AK; Nghiem PP; Cummings KJ; Lenox MW; Miller MW; Kornegay JN; Spurney CF
    J Am Heart Assoc; 2019 Aug; 8(16):e012443. PubMed ID: 31411085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral corticosteroids and onset of cardiomyopathy in Duchenne muscular dystrophy.
    Barber BJ; Andrews JG; Lu Z; West NA; Meaney FJ; Price ET; Gray A; Sheehan DW; Pandya S; Yang M; Cunniff C
    J Pediatr; 2013 Oct; 163(4):1080-4.e1. PubMed ID: 23866715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of Cardiac Dysfunction to Rhythm Abnormalities in Patients With Duchenne or Becker Muscular Dystrophies.
    Chiang DY; Allen HD; Kim JJ; Valdes SO; Wang Y; Pignatelli RH; Lotze TE; Miyake CY
    Am J Cardiol; 2016 Apr; 117(8):1349-54. PubMed ID: 26952271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.